171 related articles for article (PubMed ID: 10759564)
21. NK cell-mediated lysis is essential to kill Epstein-Barr virus transformed lymphoblastoid B cells when using rituximab.
Markasz L; Vanherberghen B; Flaberg E; Otvös R; Stuber G; Gustafsson Jernberg A; Olah E; Skribek H; Szekely L
Biomed Pharmacother; 2009 Jul; 63(6):413-20. PubMed ID: 18834693
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin inhibits proliferation of Epstein-Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression.
Vaysberg M; Balatoni CE; Nepomuceno RR; Krams SM; Martinez OM
Transplantation; 2007 Apr; 83(8):1114-21. PubMed ID: 17452903
[TBL] [Abstract][Full Text] [Related]
23. Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?
Birkeland SA; Hamilton-Dutoit S
Transplantation; 2003 Sep; 76(6):984-8. PubMed ID: 14508366
[TBL] [Abstract][Full Text] [Related]
24. Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases.
Bernasconi M; Ueda S; Krukowski P; Bornhauser BC; Ladell K; Dorner M; Sigrist JA; Campidelli C; Aslandogmus R; Alessi D; Berger C; Pileri SA; Speck RF; Nadal D
Int J Cancer; 2013 Nov; 133(10):2341-50. PubMed ID: 23640782
[TBL] [Abstract][Full Text] [Related]
25. Involvement of the gastrointestinal tract by Epstein-Barr virus--associated posttransplant lymphoproliferative disorders.
Nalesnik MA
Am J Surg Pathol; 1990; 14 Suppl 1():92-100. PubMed ID: 2158245
[TBL] [Abstract][Full Text] [Related]
26. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
Johnson LR; Nalesnik MA; Swerdlow SH
Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
[TBL] [Abstract][Full Text] [Related]
27. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
Srivastava T; Zwick DL; Rothberg PG; Warady BA
Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
[TBL] [Abstract][Full Text] [Related]
28. A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas.
Jundt F; Raetzel N; Müller C; Calkhoven CF; Kley K; Mathas S; Lietz A; Leutz A; Dörken B
Blood; 2005 Sep; 106(5):1801-7. PubMed ID: 15886325
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis and treatment of chronic allograft nephropathy with everolimus.
Lutz J; Zou H; Liu S; Antus B; Heemann U
Transplantation; 2003 Aug; 76(3):508-15. PubMed ID: 12923436
[TBL] [Abstract][Full Text] [Related]
30. Sirolimus-induced remission of posttransplantation lymphoproliferative disorder.
Cullis B; D'Souza R; McCullagh P; Harries S; Nicholls A; Lee R; Bingham C
Am J Kidney Dis; 2006 May; 47(5):e67-72. PubMed ID: 16632009
[TBL] [Abstract][Full Text] [Related]
31. Fatal Epstein-Barr virus-associated lymphoproliferative disorder following treatment with a novel mTOR inhibitor for relapsed chronic lymphocytic leukemia leukemia cells.
Götze KS; Hoffmann D; Schätzl HM; Peschel C; Fend F; Decker T
Haematologica; 2007 Sep; 92(9):1282-3. PubMed ID: 17768130
[TBL] [Abstract][Full Text] [Related]
32. Posttransplant lymphoproliferative disorder in pediatric patients.
Hussein K; Tiede C; Maecker-Kolhoff B; Kreipe H
Pathobiology; 2013; 80(6):289-96. PubMed ID: 24013821
[TBL] [Abstract][Full Text] [Related]
33. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.
Schuler W; Sedrani R; Cottens S; Häberlin B; Schulz M; Schuurman HJ; Zenke G; Zerwes HG; Schreier MH
Transplantation; 1997 Jul; 64(1):36-42. PubMed ID: 9233698
[TBL] [Abstract][Full Text] [Related]
34. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
[TBL] [Abstract][Full Text] [Related]
35. Long-term maintenance therapy for post-cardiac transplant monoclonal lymphoproliferative disorder: caveat mammalian target of rapamycin.
Khalpey Z; Miller DV; Schmitto JD; Kushwaha SS
Transplant Proc; 2011 Jun; 43(5):1893-9. PubMed ID: 21693296
[TBL] [Abstract][Full Text] [Related]
36. Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus.
Boyle TJ; Tamburini M; Berend KR; Kizilbash AM; Borowitz MJ; Lyerly HK
Surgery; 1992 Aug; 112(2):378-86. PubMed ID: 1322566
[TBL] [Abstract][Full Text] [Related]
37. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
[TBL] [Abstract][Full Text] [Related]
38. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
39. Effect of Irradiation on Incidence of Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation in Miniature Swine.
Matar AJ; Patil AR; Al-Musa A; Hanekamp I; Sachs DH; Huang CA; Duran-Struuck R
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1732-8. PubMed ID: 26210443
[TBL] [Abstract][Full Text] [Related]
40. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
Gross TG; Bucuvalas JC; Park JR; Greiner TC; Hinrich SH; Kaufman SS; Langnas AN; McDonald RA; Ryckman FC; Shaw BW; Sudan DL; Lynch JC
J Clin Oncol; 2005 Sep; 23(27):6481-8. PubMed ID: 16170157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
